UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016532
Receipt number R000019195
Scientific Title sublingual immunotherapy for Japanese cedar pollinosis
Date of disclosure of the study information 2015/02/16
Last modified on 2015/02/13 13:42:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

sublingual immunotherapy for Japanese cedar pollinosis

Acronym

SLIT for JCP

Scientific Title

sublingual immunotherapy for Japanese cedar pollinosis

Scientific Title:Acronym

SLIT for JCP

Region

Japan


Condition

Condition

Japanese cedar pollinosis

Classification by specialty

Clinical immunology Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

We evaluate the usefulness of sublingual immunotherapy against cedar pollen allergy patients

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

symptom medication score, QOL score

Key secondary outcomes

Serum cytokines


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Using the standardized cedar pollen extract, sublingual immunotherapy(sublingual-spit) is performed. Gradually increasing the extract, to reach the maintenance dose after one month.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1,There is rhinitis symptoms in more than three years during cedar pollen season
2,Intradermal test positive or IgE antibody-positive against cedar pollen
3,People who can participate in the test for 3 years in the voluntary

Key exclusion criteria

1,People that have merged with other nose disease
2,People who are using the drug for allergic disease
3,People who have oral steroid
4,People with a history of asthma
5,People who are pregnant
6,People who are breast-feeding
7,People who have serious complications
8,People who doctor has determined unsuitable

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takachika Hiroi

Organization

Tokyo Metropolitan Institute of Medical Science

Division name

Department of Genome Medicine, Pollen Allergy Project

Zip code


Address

kamikitazawa, Setagaya-ku, Tokyo

TEL

03-5316-3126

Email

hiroi-tk@igakuken.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Minoru Gotoh

Organization

Nippon Medical School

Division name

otorhinolaryngology

Zip code


Address

1-1-5 sendagi bunkyo-ku, tokyo

TEL

03-3822-2131

Homepage URL


Email

m.gotoh@nms.ac.jp


Sponsor or person

Institute

Bureau of social welfare and public health, Tokyo Metropolitan Goverment

Institute

Department

Personal name



Funding Source

Organization

Bureau of social welfare and public health, Tokyo Metropolitan Goverment

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 02 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2006 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2006 Year 05 Month 01 Day

Last follow-up date

2009 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2009 Year 10 Month 01 Day


Other

Other related information



Management information

Registered date

2015 Year 02 Month 13 Day

Last modified on

2015 Year 02 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019195


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name